Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2020 May-Jun;28(5):360–368. doi: 10.1097/PAI.0000000000000761

Table 3.

Multivariate analysis of IDO1 and WARS expression

Parameter Risk Ratio Lower 95% Upper 95% P-value
Age 2.78* 1.31 5.92 0.0079
Subtype 0.1423
 EBV/p53-wt+MSI 1.03 0.51 2.07 0.9324
 p53-ab+EMT/EBV 1.42 0.71 2.83 0.3198
TNM stage <0.0001
 T2/T1 1.55 0.73 3.29 0.2544
 T3/T2 3.34 1.85 6.03 <0.0001
 T4/T3 2.15 1.56 2.97 <0.0001
IDO1-t pos/neg 1.20 0.86 1.65 0.2816
IDO1-s pos/neg 1.11 0.81 1.53 0.5069
WARS-t pos/neg 1.41 0.98 2.04 0.0663
WARS-s pos/neg 0.82 0.55 1.23 0.3386
*

Per change in regressor over entire range